Stay updated with breaking news from Onward Transfer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If Washington State’s My Health My Data Act (“MHMDA”) “turned the beat around” on drug and device makers, then the Schrems I and II decisions by the European Court of Justice had...
On July 10, 2023, the European Commission ("Commission") adopted an adequacy decision for the EU-US Data Privacy Framework ("DPF"). In light of this decision, personal data...
Swiftly on the heels of the U.S. announcing it fulfilled its commitments for implementing the EU-U.S. Data Privacy Framework (the Framework), the European Commission (the EC) formally...
Legal Disclaimer You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or...
PRIVACY SHIELD POLICY Prior: 9-03-2019 Advertising Specialty Institute, Inc. (“ASI,” “our,” “we” or “us”) complies with the EU-US Privacy Shield Framework administered by the US Department of Commerce (together “Privacy Shield”) regarding the collection, use and retention of EU Personal Data (as defined below) This means that ASI certified that it adheres to the principles of Notice, Choice, Accountability for Onward Transfer, Security, Data Integrity and Purpose Limitation, Access and Recourse, Enforcement and Liability as defined in the Privacy Shield (“Privacy Shield ...